Articles tagged "Allocation"

2020 American Transplant Congress
The Liver Outcome Monitoring Registry Donor Risk Index: A New Measure of Deceased Donor Liver Quality
S. Kurian¹, J. Case¹, A. Robinson², B. Barrick¹, M. Prentice², C. Marsh¹
¹Scripps Center for Organ and Cell Transplantation, La Jolla, CA, ²United Network for Organ Sharing Research Department, Richmond, VA
*Purpose: The liver donor risk index (LDRI) created in 2006 evaluated the relative risk of graft failure, however its weaknesses have limited its use in…
2020 American Transplant Congress
Myosteatosis and its Impact on Graft- and Patient Survival in Adult Recipients of Deceased Donor Liver Transplantation
Z. Czigany, W. Kramp, G. van der Kroft, P. Strnad, M. Zimmermann, W. Liu, G. Wiltberger, U. Neumann, G. Lurje
University Hospital RWTH Aachen, Aachen, Germany
*Purpose: Recently our group demonstrated the role of myosteatosis in inferior perioperative outcomes (Czigany et al. Am J Transplant 2019) in recipients of orthotopic liver…
2020 American Transplant Congress
MY-ATLAS: A Novel Simulation Algorithm for Liver Transplant Allocation
C. G. Rickert¹, H. Zhao², Z. Leung², M. Akan³, J. F. Markmann¹, S. Tayur³, H. Yeh¹
¹Surgery, Massachusetts General Hospital, Boston, MA, ²City University of Hong Kong, Hong Kong, China, ³Tepper School of Business, Carnegie Mellon University, Pittsburgh, PA
*Purpose: Currently, the primary tool for modeling expected outcomes from changes in allocation policy is the SRTR-run Liver Simulated Allocation Model (LSAM), which is neither…
2020 American Transplant Congress
Does Donor Terminal, Admission or Best Estimate Glomerular Filtration Rate Predicts Kidney Transplantation Outcomes
G. Irish¹, T. Coates², P. Clayton²
¹Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia, ²Central and Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital, Adelaide, Australia
*Purpose: When assessing deceased kidney donors, a key factor is donor kidney function. It is unclear whether terminal, admission, or the best of terminal and…
2020 American Transplant Congress
Comparable Outcomes for Simultaneous Liver-Kidney Transplantation with HCV NAT-Positive Donors
M. L. Samoylova¹, B. I. Shaw¹, S. J. Kesseli¹, L. McElroy¹, Y. Patel², S. Sanoff², A. S. Barbas¹
¹Surgery, Duke University Hospital, Durham, NC, ²Medicine, Duke University Hospital, Durham, NC
*Purpose: To evaluate the impact of hepatitis C virus (HCV) Nucleic Acid Amplification-positive (NAT+) donors on outcomes following simultaneous liver-kidney (SLK) transplantation.*Methods: We used the…
2020 American Transplant Congress
The Impact of Multi-Organ Transplant Allocation Priority on Wait-Listed Isolated Kidney Transplant Candidates
S. Westphal¹, E. Langewisch¹, A. Robinson², A. Wilk², T. Plumb¹, R. Mullane¹, S. Merani¹, A. Hoffman¹, A. Maskin¹, C. Miles¹
¹University of Nebraska Medical Center, Omaha, NE, ²United Network for Organ Sharing, Richmond, VA
*Purpose: Multi-Organ Transplant (MOT) candidates involving a kidney receive higher allocation priority than kidney alone transplant (KAT) candidates. The increasing utilization of MOT has the…
2020 American Transplant Congress
Virtual XM Adversely Affects Access for Highly Sensitized African Americans Awaiting Renal Transplantation
P. T. Jindra¹, B. V. Murthy¹, C. Van Buren²
¹Surgery, Baylor College of Medicine, Houston, TX, ²Surgery, UT Medical School, Houston, TX
*Purpose: Recent UNOS policy proposals have changed kidney allocation from local Designated Service Areas (DSA) to geographic distribution areas of varying widths. Since crossmatch of…
2020 American Transplant Congress
Center Effects Substantially Explain Disparities in Access to Kidney Transplants, Yet DSA Effects Remain
D. Stewart, A. Robinson, D. Klassen, A. Wilk
United Network for Organ Sharing, Richmond, VA
*Purpose: The OPTN developed a novel methodology in 2016 to monitor equity in access to deceased donor kidney transplants (Tx) among waitlisted candidates. Results have…
2020 American Transplant Congress
A Follow-Up Over Time to the Impact of Reactive Anti-HCV and HCV NAT
C. C. Muse, C. A. Hostetler, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: A previous review from one U.S. organ procurement organization (OPO) concluded positive HCV test results yielded high rates of authorized/not recovered donors (ANR), low…
2020 American Transplant Congress
The Link between Waitlist Mortality and Access to Transplant, an Imaginative Reality
R. Batra¹, D. Mulligan¹, D. Haakinson¹, S. Noreen², D. Stewart², G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Liver transplant waitlist mortality due to inadequate access to livers is the Achilles heel in liver transplantation in United States. This remains amongst the…